Eliza Chakravarty to Maternal Exposure
This is a "connection" page, showing publications Eliza Chakravarty has written about Maternal Exposure.
Connection Strength
1.131
-
The new FDA labeling rule: impact on prescribing rheumatological medications during pregnancy. Rheumatology (Oxford). 2018 07 01; 57(suppl_5):v2-v8.
Score: 0.614
-
Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011 Feb 03; 117(5):1499-506.
Score: 0.363
-
Power in numbers. Rheumatology (Oxford). 2018 07 01; 57(suppl_5):v40-v47.
Score: 0.154